Type
. Immunopathology of leprosy skin lesions. Seminars in dermatology. 1991;10(3):188-93.
Type
. Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy. Immunological reviews. 1991;121:171-91.
Type
. Evaluation of genotoxicity of clofazimine, an antileprosy drug, in mice in vivo. III. Sister chromatid exchange analysis in bone marrow cells. In vivo (Athens, Greece). 1991;5(1):69-70.
Type
. Correction of severe foot deformities. Acta orthopaedica Belgica. 1991;57 Suppl 1:8-15.
Type
. [The campaign against leprosy]. Revue d'epidemiologie et de sante publique. 1991;39(3):326-7.
Type
. Social inequality, urban growth and leprosy in Manaus: a spatial approach. Revista de saude publica [Internet]. 2009;43(4):656-65. Available from: http://www.scielosp.org/pdf/rsp/v43n4/en_842.pdf
Type
. Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy. BMC medical genetics. 2009;10:65.
Type
. The diarylquinoline R207910 is bactericidal against Mycobacterium leprae in mice at low dose and administered intermittently. Antimicrobial agents and chemotherapy. 2009;53(9):3989-91.
Type
. CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection. The American Journal of dermatopathology. 2009;31(6):527-31.
Type
. Leprosy: a diagnostic trap for dermatopathologists in nonendemic area. The American Journal of dermatopathology. 2009;31(6):607-10.
Pagination
- Previous page
- Page 2090
- Next page